KMTS
KESTRA MEDICAL TECHNOLOGIES, LTD.
$20.85
+3.53%
$1.2B
No data for this timeframe.
Vol
Market Cap$1.2B
Cap SizeSmall Cap
Analyst ConsensusStrong Buy (85%)
Insider Activity1B / 3S
Insider Net $-$572.4K
SEC Reports3
Press Releases2
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. D0·CIK 0001877184·Prev Close $20.14
Recent Activity
Jun 3, 2026
Insider
Webster Brian Daniel was granted 75,681 shares
See Remarks
Jun 3, 2026
Insider
Umberger Traci S was granted 25,227 shares
See Remarks
Jun 3, 2026
Insider
Mahboob Vaseem was granted 25,227 shares
Chief Financial Officer
May 16, 2026
SEC
BTIG initiates KMTS at Buy with $32 PT (+47%) — 6-firm cluster signals sector-wide conviction
ANALYST-UPGRADE — Impact 3/10
Apr 29, 2026
other
Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
<p align="justify">KIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies
Apr 16, 2026
SEC
BTIG initiates KMTS with Buy rating and $32 PT — 59% upside to mean target
ANALYST-UPGRADE — Impact 2/10
Apr 1, 2026
SEC
Kestra Medical Technologies filed an S-3ASR shelf registration for an indeterminate amount of common shares, enabling fu
S-3ASR — Impact 3/10
Mar 17, 2026
Press
Kestra Medical Technologies reported strong Q3 FY26 financial results with revenue of $24.6 million, up 63% year-over-ye
Impact 8/10
Price Targets
$27.71
+32.9% upside
Strong Buy
Current $20.85
Low $17.00
Median $30.00
High $30.00
7 analysts
$17.00
$30.00
Analyst Ratings
6Strong Buy
5Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 9, 2026 | Goldman Sachs | MAINTAIN | Neutral → Neutral |
| Apr 7, 2026 | BTIG | REITERATE | Buy → Buy |
| Mar 25, 2026 | BTIG | REITERATE | Buy → Buy |
| Mar 18, 2026 | BTIG | REITERATE | Buy → Buy |
| Dec 15, 2025 | Goldman Sachs | MAINTAIN | Neutral → Neutral |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.58 | $-0.61 — $-0.55 | 50% YoY | 2 |
| Next Q | $-0.54 | $-0.55 — $-0.53 | -51% YoY | 2 |
| Current FY | $-2.33 | $-2.36 — $-2.30 | 40% YoY | 2 |
| Next FY | $-2.14 | $-2.37 — $-1.91 | 8% YoY | 2 |
Latest Reports
BULLISH
ANALYST-UPGRADE
3/10
BTIG initiates KMTS at Buy with $32 PT (+47%) — 6-firm cluster signals sector-wide conviction
May 16, 2026
BULLISH
ANALYST-UPGRADE
2/10
BTIG initiates KMTS with Buy rating and $32 PT — 59% upside to mean target
Apr 16, 2026
BULLISH
Press
8/10
Kestra Medical Technologies reported strong Q3 FY26 financial results with revenue of $24.6 million, up 63% year-over-ye
Mar 17, 2026
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 3, 2026 | Webster Brian | A | $0.00 |
| Jun 3, 2026 | Umberger Traci | A | $0.00 |
| Jun 3, 2026 | Mahboob Vaseem | A | $0.00 |
| Jun 3, 2026 | Ford Alfred | A | $0.00 |
| Jun 3, 2026 | Moran Timothy | A | $0.00 |
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
7 unique insiders with 10 transactions. Net insider value: -$572.4K ($199.8K bought, $772.2K sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 3, 2026 | Webster Brian Daniel | See Remarks | AWARD | 75,681 | — | — |
| Jun 3, 2026 | Umberger Traci S | See Remarks | AWARD | 25,227 | — | — |
| Jun 3, 2026 | Mahboob Vaseem | Chief Financial Officer | AWARD | 25,227 | — | — |
| Jun 3, 2026 | Ford Alfred J Jr | Chief Commercial Officer | AWARD | 25,227 | — | — |
| Jun 3, 2026 | Moran Timothy P. | Chief Business Officer | AWARD | 22,704 | — | — |
| May 15, 2026 | Webster Brian Daniel | See Remarks | SELL | 8,155 | $20.53 | $167.4K |
| Apr 15, 2026 | Webster Brian Daniel | See Remarks | SELL | 15,000 | $20.04 | $300.7K |
| Mar 26, 2026 | COHEN RAYMOND W | Director | BUY | 10,000 | $19.98 | $199.8K |
| Mar 17, 2026 | Webster Brian Daniel | See Remarks | SELL | 15,000 | $20.27 | $304.1K |
| Mar 11, 2026 | Reilly Kevin C | Director | AWARD | 8,300 | — | — |
3 SEC filing reports analyzed. Sentiment: 2 bullish, 0 bearish, 0 mixed, 1 neutral. Avg impact: 2.7/10.
BULLISH
ANALYST-UPGRADE
2/10
BTIG initiates KMTS with Buy rating and $32 PT — 59% upside to mean target
Apr 16, 2026
BULLISH
ANALYST-UPGRADE
3/10
BTIG initiates KMTS at Buy with $32 PT (+47%) — 6-firm cluster signals sector-wide conviction
May 16, 2026
NEUTRAL
S-3ASR
3/10
Kestra Medical Technologies filed an S-3ASR shelf registration for an indeterminate amount of common
Apr 1, 2026
Current analyst consensus: Strong Buy (85% buy). Based on 13 analysts: 6 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$27.71 mean target
+32.9% upside
Strong Buy (3.00)
$17.00 Low
$30.00 High
| Metric | Value |
|---|---|
| Current Price | $20.85 |
| Target Low | $17.00 |
| Target Mean | $27.71 |
| Target Median | $30.00 |
| Target High | $30.00 |
| # Analysts | 7 |
| Recommendation | Strong Buy (3.00) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-04-30 |
$-0.58 | $-0.61 | $-0.55 | 49.6% | +0.0% | 1↑ 1↓ | $0.0B | 53.7% | 2 |
| Next Q 2026-07-31 |
$-0.54 | $-0.55 | $-0.53 | -50.7% | +0.0% | 1↑ 1↓ | $0.0B | 44.7% | 2 |
| Current FY 2026-04-30 |
$-2.33 | $-2.36 | $-2.30 | 40.4% | +0.0% | 1↑ 1↓ | $0.1B | 55.4% | 2 |
| Next FY 2027-04-30 |
$-2.14 | $-2.37 | $-1.91 | 8.1% | +0.0% | 1↑ 1↓ | $0.1B | 42.9% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.580 | |
| 7d ago | $-0.580 | |
| 30d ago | $-0.580 | |
| 60d ago | $-0.575 | -0.005 |
| 90d ago | $-0.575 | -0.005 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 9, 2026 | Goldman Sachs | MAINTAIN | Neutral | Neutral |
| Apr 7, 2026 | BTIG | REITERATE | Buy | Buy |
| Mar 25, 2026 | BTIG | REITERATE | Buy | Buy |
| Mar 18, 2026 | BTIG | REITERATE | Buy | Buy |
| Dec 15, 2025 | Goldman Sachs | MAINTAIN | Neutral | Neutral |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 5 | 2 | 0 | 0 | 85% | |
| May 1, 2026 | 6 | 5 | 2 | 0 | 0 | 85% | |
| Apr 1, 2026 | 6 | 5 | 2 | 0 | 0 | 85% | |
| Mar 1, 2026 | 6 | 5 | 2 | 0 | 0 | 85% | |
| Feb 1, 2026 | 6 | 5 | 2 | 0 | 0 | 85% | |
| Jan 1, 2026 | 6 | 5 | 2 | 0 | 0 | 85% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Apr 29, 2026
other
Kestra Medical Technologies to Present at the BofA Securities 2026 Healthcare Conference
<p align="justify">KIRKLAND, Wash., April 29, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical
Apr 23, 2026
short_interest
FTD: KMTS — 39,553 shares ($0.9M) failed to deliver
Settlement: 20260423, Price: $23.81, FTD Value: $941,756.93, KESTRA MED TECHNOLOGIES LTD SH
Mar 25, 2026
other
Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”
<p align="justify">KIRKLAND, Wash., March 25, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical
Mar 25, 2026
short_interest
FTD: KMTS — 67,613 shares ($1.4M) failed to deliver
Settlement: 20260325, Price: $20.70, FTD Value: $1,399,589.1, KESTRA MED TECHNOLOGIES LTD SH
Mar 24, 2026
short_interest
FTD: KMTS — 77,412 shares ($1.5M) failed to deliver
Settlement: 20260324, Price: $19.59, FTD Value: $1,516,501.08, KESTRA MED TECHNOLOGIES LTD SH
Mar 23, 2026
short_interest
FTD: KMTS — 75,194 shares ($1.4M) failed to deliver
Settlement: 20260323, Price: $19.10, FTD Value: $1,436,205.4, KESTRA MED TECHNOLOGIES LTD SH
Mar 18, 2026
short_interest
FTD: KMTS — 37,683 shares ($0.8M) failed to deliver
Settlement: 20260318, Price: $21.14, FTD Value: $796,618.62, KESTRA MED TECHNOLOGIES LTD SH
Mar 17, 2026
earnings
Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results
<p align="justify">KIRKLAND, Wash., March 17, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical
Mar 17, 2026
earnings_calendar
KMTS Q3 2026 Earnings Scheduled — 2026-03-17
Mar 17, 2026
short_interest
FTD: KMTS — 31,625 shares ($0.6M) failed to deliver
Settlement: 20260317, Price: $19.26, FTD Value: $609,097.5, KESTRA MED TECHNOLOGIES LTD SH
Mar 16, 2026
short_interest
FTD: KMTS — 32,727 shares ($0.6M) failed to deliver
Settlement: 20260316, Price: $19.08, FTD Value: $624,431.16, KESTRA MED TECHNOLOGIES LTD SH
Mar 3, 2026
earnings
Kestra Medical Technologies to Report Third Quarter Fiscal 2026 Financial Results on March 17
<p align="justify">KIRKLAND, Wash., March 03, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical